Sullivan HW[au] - Search Results

Year	Number of Results
1975	1
1984	1
1985	1
1986	2
2005	1
2007	1
2008	3
2009	4
2010	2
2011	1
2013	3
2014	6
2015	5
2016	11
2017	5
2018	5
2019	6
2020	6
2021	5
2022	4
2023	0

1

Patients' understanding of oncology clinical endpoints: A literature review.

Boudewyns V, Southwell BG, DeFrank JT, Ferriola-Bruckenstein K, Halpern MT, O'Donoghue AC, Sullivan HW. Boudewyns V, et al. Among authors: sullivan hw. Patient Educ Couns. 2020 Sep;103(9):1724-1735. doi: 10.1016/j.pec.2020.03.018. Epub 2020 Mar 20. Patient Educ Couns. 2020. PMID: 32273145 Free PMC article. Review.

2

Character-space-limited online prescription drug communications: Four experimental studies.

Sullivan HW, O'Donoghue A, Mannis S, Carpenter AM. Sullivan HW, et al. Res Social Adm Pharm. 2022 Dec;18(12):4092-4099. doi: 10.1016/j.sapharm.2022.07.048. Epub 2022 Aug 5. Res Social Adm Pharm. 2022. PMID: 35961860 Free article.

3

Physicians' use of and preferences for FDA-approved prescribing information.

Sullivan HW, Squire C, Aikin KJ, Tzeng J, Ferriola-Bruckenstein K, Brodsky E, Trentacosti AM, Johnson M. Sullivan HW, et al. Res Social Adm Pharm. 2022 Jun;18(6):3027-3037. doi: 10.1016/j.sapharm.2021.07.028. Epub 2021 Aug 1. Res Social Adm Pharm. 2022. PMID: 34364803

4

Prescribers' Knowledge and Skills for Interpreting Research Results: A Systematic Review.

Kahwati L, Carmody D, Berkman N, Sullivan HW, Aikin KJ, DeFrank J. Kahwati L, et al. Among authors: sullivan hw. J Contin Educ Health Prof. 2017 Spring;37(2):129-136. doi: 10.1097/CEH.0000000000000150. J Contin Educ Health Prof. 2017. PMID: 28562502 Free PMC article. Review.

5

Communicating quantitative risks and benefits in promotional prescription drug labeling or print advertising.

West SL, Squiers LB, McCormack L, Southwell BG, Brouwer ES, Ashok M, Lux L, Boudewyns V, O'Donoghue A, Sullivan HW. West SL, et al. Among authors: sullivan hw. Pharmacoepidemiol Drug Saf. 2013 May;22(5):447-58. doi: 10.1002/pds.3416. Epub 2013 Feb 26. Pharmacoepidemiol Drug Saf. 2013. PMID: 23440924 Review.

6

Direct-to-Consumer Prescription Drug Advertising and Patient-Provider Interactions.

Sullivan HW, Aikin KJ, Berktold J, Stein KL, Hoverman VJ. Sullivan HW, et al. J Am Board Fam Med. 2020 Mar-Apr;33(2):279-283. doi: 10.3122/jabfm.2020.02.190278. J Am Board Fam Med. 2020. PMID: 32179611 Free article.

7

Attention to risk information in direct-to-consumer prescription drug print ads: An eye-tracking study.

Aikin KJ, Sullivan HW, Caporaso A, Hoverman V, Yan T, Williams D, Crafts J. Aikin KJ, et al. Among authors: sullivan hw. Pharmacoepidemiol Drug Saf. 2022 Jul 21. doi: 10.1002/pds.5511. Online ahead of print. Pharmacoepidemiol Drug Saf. 2022. PMID: 35864719

8

Quantitative Information on Oncology Prescription Drug Websites.

Sullivan HW, Aikin KJ, Squiers LB. Sullivan HW, et al. J Cancer Educ. 2018 Apr;33(2):371-374. doi: 10.1007/s13187-016-1107-1. J Cancer Educ. 2018. PMID: 27589969 Free PMC article.

9

Visual images of prescription drug benefits in direct-to-consumer television advertisements.

Sullivan HW, O'Donoghue AC, Lynch M, Johnson M, Davis C, Amoozegar JB, Rupert DJ. Sullivan HW, et al. Patient Educ Couns. 2021 Sep;104(9):2240-2249. doi: 10.1016/j.pec.2021.02.024. Epub 2021 Feb 13. Patient Educ Couns. 2021. PMID: 33618970 Free PMC article.

10

Consumers' experience with and attitudes toward direct-to-consumer prescription drug promotion: a nationally representative survey.

Aikin KJ, Sullivan HW, Berktold J, Stein KL, Hoverman VJ. Aikin KJ, et al. Among authors: sullivan hw. Health Mark Q. 2021 Jan-Mar;38(1):1-11. doi: 10.1080/07359683.2021.1947067. Epub 2021 Jul 9. Health Mark Q. 2021. PMID: 34238134 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results